Skip to main content
. 2019 May 8;317(1):F197–F206. doi: 10.1152/ajprenal.00090.2019

Fig. 1.

Fig. 1.

Comparison of changes in body weights and bladder weights between doxorubicin (DOX)-administered and control (Ctrl) groups. Body weight was measured at 6 days after the administration and expressed as the change relative to that on the day before the first administration, shown as 0 (left). Bladder weight was measured at 1 wk after the sixth administration of agents and expressed as a percentage of the body weight (right). Values are means ± SE. *P < 0.05 and †P < 0.005 vs. control mice.